NCT01893892View on ClinicalTrials.gov

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Musculoskeletal Complications
Interventions
DIETARY_SUPPLEMENT

levocarnitine

Given PO

OTHER

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT01893892 - Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms | Biotech Hunter | Biotech Hunter